These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 16211715)

  • 1. Survival following the development of ascites and/or peripheral oedema in primary biliary cirrhosis: a staged prognostic model.
    Chan CW; Carpenter JR; Rigamonti C; Gunsar F; Burroughs AK
    Scand J Gastroenterol; 2005 Sep; 40(9):1081-9. PubMed ID: 16211715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting the advent of ascites and other complications in primary biliary cirrhosis: a staged model approach.
    Chan CW; Tsochatzis EA; Carpenter JR; Rigamonti C; Gunsar F; Burroughs AK
    Aliment Pharmacol Ther; 2010 Mar; 31(5):573-82. PubMed ID: 20003096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Major clinical events, signs and severity assessment scores related to actual survival in patients who died from primary biliary cirrhosis. A long-term historical cohort study.
    van Dam GM; Gips CH; Reisman Y; Maas KW; Purmer IM; Huizenga JR; Verbaan BW
    Hepatogastroenterology; 1999; 46(25):108-15. PubMed ID: 10228773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary biliary cirrhosis: prediction of short-term survival based on repeated patient visits.
    Murtaugh PA; Dickson ER; Van Dam GM; Malinchoc M; Grambsch PM; Langworthy AL; Gips CH
    Hepatology; 1994 Jul; 20(1 Pt 1):126-34. PubMed ID: 8020881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Updating prognosis in primary biliary cirrhosis using a time-dependent Cox regression model. PBC1 and PBC2 trial groups.
    Christensen E; Altman DG; Neuberger J; De Stavola BL; Tygstrup N; Williams R
    Gastroenterology; 1993 Dec; 105(6):1865-76. PubMed ID: 8253362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival probabilities of Pugh-Child-PBC classified patients in the euricterus primary biliary cirrhosis population, based on the Mayo clinic prognostic model. Euricterus Project Management Group.
    Reisman Y; van Dam GM; Gips CH; Lavelle SM; Euricterus PM
    Hepatogastroenterology; 1997; 44(16):982-9. PubMed ID: 9261586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary biliary cirrhosis: Dutch application of the Mayo Model before and after orthotopic liver transplantation.
    van Dam GM; Verbaan BW; Therneau TM; Dickson ER; Malinchoc M; Murtaugh PA; Huizenga JR; Gips CH
    Hepatogastroenterology; 1997; 44(15):732-43. PubMed ID: 9222682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Value of Biochemical Response Models for Primary Biliary Cholangitis and the Additional Role of the Neutrophil-to-Lymphocyte Ratio.
    Yoo JJ; Cho EJ; Lee B; Kim SG; Kim YS; Lee YB; Lee JH; Yu SJ; Kim YJ; Yoon JH
    Gut Liver; 2018 Nov; 12(6):714-721. PubMed ID: 30400732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognosis of ursodeoxycholic Acid-treated patients with primary biliary cirrhosis. Results of a 10-yr cohort study involving 297 patients.
    ter Borg PC; Schalm SW; Hansen BE; van Buuren HR;
    Am J Gastroenterol; 2006 Sep; 101(9):2044-50. PubMed ID: 16848809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New simple prognostic score for primary biliary cirrhosis: Albumin-bilirubin score.
    Chan AW; Chan RC; Wong GL; Wong VW; Choi PC; Chan HL; To KF
    J Gastroenterol Hepatol; 2015 Sep; 30(9):1391-6. PubMed ID: 25753927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of baseline platelet count for prediction of complications in primary biliary cirrhosis patients treated with ursodeoxycholic acid.
    Huang YL; Yao DK; Hu ZD; Sun Y; Chen SX; Zhong RQ; Deng AM
    Scand J Clin Lab Invest; 2013 Feb; 73(1):17-23. PubMed ID: 23294193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival and symptom progression in a geographically based cohort of patients with primary biliary cirrhosis: follow-up for up to 28 years.
    Prince M; Chetwynd A; Newman W; Metcalf JV; James OF
    Gastroenterology; 2002 Oct; 123(4):1044-51. PubMed ID: 12360466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural history and prognostic factors of primary biliary cirrhosis in Taiwan: a follow-up study up to 18 years.
    Su CW; Hung HH; Huo TI; Huang YH; Li CP; Lin HC; Lee PC; Lee SD; Wu JC
    Liver Int; 2008 Nov; 28(9):1305-13. PubMed ID: 18346129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mean arterial pressure drop is an independent risk factor of death in patients with HBV-related cirrhosis ascites.
    Li H; Guo Z; Yang X; Sun D
    Turk J Gastroenterol; 2017 Jan; 28(1):26-30. PubMed ID: 27991854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of the Mayo primary biliary cirrhosis survival model to Mayo liver transplant patients.
    Grambsch PM; Dickson ER; Wiesner RH; Langworthy A
    Mayo Clin Proc; 1989 Jun; 64(6):699-704. PubMed ID: 2664365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is serum bilirubin concentration the only valid prognostic marker in primary biliary cirrhosis?
    Krzeski P; Zych W; Kraszewska E; Milewski B; Butruk E; Habior A
    Hepatology; 1999 Oct; 30(4):865-9. PubMed ID: 10498635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacterial Infections Change Natural History of Cirrhosis Irrespective of Liver Disease Severity.
    Dionigi E; Garcovich M; Borzio M; Leandro G; Majumdar A; Tsami A; Arvaniti V; Roccarina D; Pinzani M; Burroughs AK; O'Beirne J; Tsochatzis EA
    Am J Gastroenterol; 2017 Apr; 112(4):588-596. PubMed ID: 28220780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical features and prognosis of primary biliary cirrhosis in Korea].
    Kim KA; Jeong SH; Lee JI; Yeon JE; Lee HJ; Kwon SY; Chang UI; Min HJ
    Korean J Hepatol; 2010 Jun; 16(2):139-46. PubMed ID: 20606498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and Validation of a Scoring System to Predict Outcomes of Patients With Primary Biliary Cirrhosis Receiving Ursodeoxycholic Acid Therapy.
    Lammers WJ; Hirschfield GM; Corpechot C; Nevens F; Lindor KD; Janssen HL; Floreani A; Ponsioen CY; Mayo MJ; Invernizzi P; Battezzati PM; Parés A; Burroughs AK; Mason AL; Kowdley KV; Kumagi T; Harms MH; Trivedi PJ; Poupon R; Cheung A; Lleo A; Caballeria L; Hansen BE; van Buuren HR;
    Gastroenterology; 2015 Dec; 149(7):1804-1812.e4. PubMed ID: 26261009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of histological staging systems for primary biliary cirrhosis: correlation with clinical and biochemical factors and significance of pathological parameters in prognostication.
    Chan AW; Chan RC; Wong GL; Wong VW; Choi PC; Chan HL; To KF
    Histopathology; 2014 Aug; 65(2):174-86. PubMed ID: 24479738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.